I-Mab Biopharma is a global biotech company focused on the development of precision immuno-oncology agents for the treatment of cancer, particularly with its key product, givastomig, aimed at Claudin 18
I-Mab Biopharma is a global biotech company focused on the development of precision immuno-oncology agents for the treatment of cancer, particularly with its key product, givastomig, aimed at Claudin 18.2 positive gastric cancers.